Biohybrid Micro-Robots for Targeted Drug Delivery in Cancer Therapy †

Abstract

The development of biohybrid micro-robots represents a groundbreaking advancement in targeted drug delivery for cancer therapy, offering unprecedented precision and reduced systemic toxicity. These microscale robots integrate synthetic materials with biological components such as bacteria, algae, red blood cells, or spermatozoa, capitalizing on the inherent motility, biocompatibility, and targeting capabilities of living organisms. This hybridization enables active navigation through complex biological environments, overcoming physiological barriers such as the blood–brain and endothelial junctions that impede traditional nanoparticle-based systems. In this study, we propose a multi-functional biohybrid micro-robotic platform composed of magnetically actuated synthetic chassis coated with doxorubicin-loaded lipid vesicles and tethered to Magnetospirillum magneticum for propulsion and tumor-homing capabilities. The results underscore the promise of biohybrid micro-robots as intelligent, minimally invasive agents for next-generation oncological therapies, capable of delivering chemotherapeutics with enhanced spatial and temporal accuracy. Future work will focus on clinical translation pathways, biosafety evaluations, and scalability of production under Good Manufacturing Practice (GMP) standards.